Bio

Dr. Jonathan Zung '86 is Vice President and head of Global Development Operations (GDO) at Bristol-Myers Squibb in Princeton, NJ. Global Development Operations integrates all key functions involved in setting up and managing the conduct of clinical trials, site monitoring, data management and review across all therapeutic areas from phase II through registration. The organization consists of 1300+ staff at 19 centers and operates in over 45 countries. Jonathan joined Bristol-Myers Squibb in December 2001 as Executive Director of Project Management. Since joining BMS he has held positions of increasing responsibility, including head of Global Project Management. He was responsible for and led the integration of the $2.1 Billion Medarex acquisition in 2009.

Before Bristol-Myers Squibb, Jonathan was with Pfizer Global Research and Development in Groton, CT from 1991 through 2001. At Pfizer, he held various positions, with increasing responsibility in the Analytical Research and Development (AR&D) Department and the Global Project Management organization. While in AR&D he led a group of scientists that supported the development and registration of GeodonIM, along with new and novel dosage forms for the line of extension of approved Pfizer products (Zithromax, Zoloft, and Zyrtec).

<p">Jonathan received his Ph.D. in Analytical Chemistry from Emory University, Atlanta, Georgia, and his B.S. degree in Chemistry from the Florida Institute of Technology, Melbourne, Florida. He was named a member of The Florida Institute of Technology Board of Trustees in 2010. Jonathan is also chair of the Operations Committee for TransCelerate BioPharma.